Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × Atorvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Prostatic Neoplasms 9 Neoplasms 4 Endometrial Neoplasms 3 Colonic Neoplasms 3 Cardiotoxicity 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Leukemia, Myeloid, Acute 2 Heart Failure 2 Glioblastoma 2 Endometrial Hyperplasia 2 Colorectal Neoplasms 2 Cardiovascular Diseases 2 Venous Thrombosis 1 Smoking 1 Pulmonary Disease, Chronic Obstructive 1 Precancerous Conditions 1 Overall Survival 1 Ototoxicity 1 Neoplastic Cells, Circulating 1 Neoplasms, Plasma Cell 1 Nasopharyngeal Carcinoma 1 Melanoma 1

Interventions

Dexamethasone 98 Cyclophosphamide 86 Melphalan 78 Bortezomib 60 Peripheral Blood Stem Cell Transplantation 52 Lenalidomide 49 Busulfan 43 fludarabine phosphate 41 Filgrastim 41 Thalidomide 31 Radiotherapy 31 Antilymphocyte Serum 31 Tacrolimus 28 Mycophenolic Acid 23 fludarabine 21 Etoposide 21 Cyclosporine 21 Prednisone 20 Calcium Dobesilate 20 Methotrexate 19 Whole-Body Irradiation 18 Methylprednisolone 18 carfilzomib 16 pomalidomide 15 sargramostim 14 daratumumab 13 Granulocyte Colony-Stimulating Factor 13 Rituximab 12 Interferon-alpha 12 Cord Blood Stem Cell Transplantation 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00164086 2006-10-11

Atorvastatin in Myeloma

Bayside Health

Phase 1 Unknown

Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡